HEAL1000

HEAL1000

Natural Sciences

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
1-1 of 1 ARTICLE
https://doi.org/10.12688/f1000research.136087.2
Brief Report metrics
Revised
Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition
[version 2; peer review: 2 approved]
Peer Reviewers Konstantinos Kamposioras; Athanasia Pavlopoulou
  • Funder
  • European Union and Greek national funds, Operational Program Competitiveness, Entrepreneurship and Innovation, under RESEARCH—CREATE—INNOVATE
LATEST VERSION PUBLISHED 14 Jun 2024
1-1 of 1 ARTICLE
Gateway Areas
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.